Beijing Fino Weikang Biotechnology Co., Ltd.

Confirm

Consulting Dynamics

Enterprise News

Industry dynamics

Dec 11,2023

P4 The 7th Cancer Precision Medicine Conference of 2023 Ends Successfully

From December 7 to 8, P4 2023's 7th tumor precision medical conference was held in Crowne Plaza Beijing Chaoyang Youtang. P4 Conference is an annual professional brand event accurately positioned in the field of tumor precision. In this conference, more than 60 academicians/regulators/clinicians/scientific research authoritative experts and KOL, a precision pharmaceutical company/diagnostic company, led the attendance and conducted special speeches or round-table discussions. More than 1000 representatives of industry elites in the field of precision medicine gathered at the scene. As one of the exhibitors, Finowicom participated in it and had a rich exchange with many participants.

P4 The 7th Cancer Precision Medicine Conference of 2023 Ends Successfully

Dec 05,2023

Signing Cooperation | Collaborative Innovation and Development of Medical Workers and the Second Qilu Medical Discipline Integration and Achievement Transformation Summit Forum Held Successfully

On November 30, sponsored by the Management Committee of Jinan International Medical Center and jointly organized by Jinan Medical Development Group Co., Ltd. and Shandong University Pharmaceutical Industry Alumni Association, the "Medical Industry Collaborative Innovation and Development and the second Qilu Medicine discipline Integration and achievement Transformation Summit Forum" was successfully held in Jinan International Medical Center. More than 100 experts, scholars and industry leaders gathered together to look forward to the bright future of collaborative innovation and development of medical workers and share the gratifying achievements of Qilu medicine. Huaiyin District Party Committee Secretary, Jinan International Medical Center Party Committee Secretary Sun Changjian presided over the opening ceremony. Lei Jie, chairman of the CPPCC and commander-in-chief of the construction headquarters of Jinan International Medical Center, attended the event and delivered a speech.

Signing Cooperation | Collaborative Innovation and Development of Medical Workers and the Second Qilu Medical Discipline Integration and Achievement Transformation Summit Forum Held Successfully

Dec 01,2023

Meeting Invitation | Finowicom Invites You to Join P4 2023 for the 7th Cancer Precision Medicine Conference

P4 2023's 7th International Conference on Precision Oncology Medicine will be set sail again in Beijing from December 7 to 8, with more than 60 academicians/regulators/clinicians/scientific research authoritative experts and KOL, a precision drug company/diagnostic company, leading the attendance, and more than 1000 industry elite representatives in the field of precision medicine gathered at the scene. The conference will discuss the industry's pain points and annual hot topics in depth, and explore the latest regulations on tumor precision medicine, early screening/diagnostic technology innovation and commercialization path, immunotherapy/targeted drug precision development, clinical precision medicine/diagnosis and treatment path with industry experts!

Meeting Invitation | Finowicom Invites You to Join P4 2023 for the 7th Cancer Precision Medicine Conference

Nov 17,2023

The 3rd CIBM Biometrics Development Conference and the 2nd Biological Standards Technology Exchange Conference were successfully held in Zhengzhou, Henan Province

On November 7, the 3rd CIBM Biometrics Development Conference and the 2nd Biological Standards Technology Exchange Conference were grandly opened in Zhengzhou City, Henan Province. The conference attracted many academicians, experts, government managers and entrepreneurs from the fields of biometrics, standardization, life sciences, biological industry and other fields to carry out in-depth exchanges of policy, research, academic and industry. The theme of the conference report is closely focused on the high-quality development of biotechnology and bioeconomy, which is in line with the goal of China's modernization.

The 3rd CIBM Biometrics Development Conference and the 2nd Biological Standards Technology Exchange Conference were successfully held in Zhengzhou, Henan Province

Nov 17,2023

High-definition panoramic tissue imaging and AI quantitative analysis technology training course ended successfully!

From November 9 to 10, the "High Definition Panoramic Tissue Imaging and AI Quantitative Analysis Technology Training Course" sponsored by the Institute of Brain Science of Fudan University and co-sponsored by Shanghai Jiangwen and various product technology companies was successfully held in Fudan Brain Institute. Major players in various fields gathered together to launch a deep ideological collision.

High-definition panoramic tissue imaging and AI quantitative analysis technology training course ended successfully!

Nov 08,2023

Application Sharing Topic 1 | Thinking of Multi-target Detection in Situ of Pancreatic Cancer

On October 27, 2023, Professor Wu, a well-known public health expert and chief epidemiologist of the Chinese Center for Disease Control and prevention, died of pancreatic cancer at the age of 60. Pancreatic cancer, the "king of cancer", once again entered the public eye. Prior to this, "the father of Apple" Jobs, the famous tenor Pavarotti and others were also diagnosed with pancreatic cancer and fought against cancer for years, and finally passed away. The reason why pancreatic cancer is called "the king of cancer" is that its early symptoms are not obvious, and the onset is often in the middle and late stages. At the same time, the pancreas is hidden in the depth of the abdominal cavity, and the surrounding blood supply is rich and easy to transfer, and pancreatic cancer is a primary, congenital drug-resistant disease, and the effective rate of drug treatment is very low.

Application Sharing Topic 1 | Thinking of Multi-target Detection in Situ of Pancreatic Cancer
< 123 >